Related Experiment Video

Updated: Jun 5, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Revascularization treatment of stable coronary artery disease

Michael Magro1, Scot Garg, Patrick W Serruys

  • 1Thoraxcenter, Erasmus MC, Ba-583, Dr Molewaterplein 40, Rotterdam, The Netherlands.

Expert Opinion on Pharmacotherapy
|January 14, 2011
PubMed

Insights

Coronary artery disease (CAD) management involves optimal medical therapy, with revascularization via coronary artery bypass surgery (CABG) or percutaneous coronary intervention (PCI) offering benefits for severe symptoms and specific patient groups. Advances in PCI, particularly drug-eluting stents, are improving treatment outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Coronary artery disease (CAD) is a primary cause of mortality globally.
  • Manifestations of coronary atherosclerosis, including angina and myocardial infarction, cause significant morbidity and healthcare costs.

Purpose of the Study:

  • To review recent advancements in the treatment of coronary artery disease (CAD).
  • To compare medical therapy, coronary artery bypass surgery (CABG), and percutaneous coronary intervention (PCI) for CAD management.

Main Methods:

  • Review of current literature on CAD treatment strategies.
  • Analysis of the roles of medical therapy, CABG, and PCI.
  • Evaluation of technological advancements, such as drug-eluting stents.

Main Results:

  • Optimal medical treatment is fundamental for CAD management.
  • Revascularization (CABG or PCI) provides superior symptom control for severe cases.
  • PCI, especially with drug-eluting stents, has become increasingly comparable to CABG.

Conclusions:

  • Ongoing research is crucial for evidence-based decisions in CAD treatment.
  • Future trials should focus on cost-effectiveness and optimal strategy selection for diverse patient populations.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...